MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3

Prostate cancer (PCa) testing is currently based on measurement of serum prostate-specific antigen levels and digital rectal examination, which are limited by a low predictive value and the adverse effects associated with overdiagnosis and overtreatment. Recent studies have reported that the abnorma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xin-Min, Zhang, Peng, Liu, Man-Hua, Chen, Ping, Zhang, Wei-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317654/
https://www.ncbi.nlm.nih.gov/pubmed/30483762
http://dx.doi.org/10.3892/ijo.2018.4647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317654/
https://www.ncbi.nlm.nih.gov/pubmed/30483762
http://dx.doi.org/10.3892/ijo.2018.4647

Ejemplares similares